Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Intimation of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has informed BSE that its Board of Directors will meet on 14 August 2025. The meeting will, among other things, consider and approve certain items as per the agenda. No specific agenda items, financial results, or corporate actions have been disclosed in this intimation. The exact matters to be discussed will typically be communicated after the meeting concludes. This is a routine regulatory filing required under SEBI's listing norms ahead of any material board decision.
This is a standard advance notice with no specific business action disclosed, so it is unlikely to move the stock price on its own. Investors should watch for the outcome of the meeting, as undisclosed agenda items could include results, dividends, fundraising, or other material decisions.